Adherence to medications and associated factors: A cross-sectional study among Palestinian hypertensive patients  by Al-Ramahi, Rowa’
Journal of Epidemiology and Global Health (2015) 5, 125–132http : / / www.elsev ier .com/ locateAdherence to medications and associated
factors: A cross-sectional study among
Palestinian hypertensive patientshttp://dx.doi.org/10.1016/j.jegh.2014.05.005
2210-6006/ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
* Tel.: +972 9 2345113.
E-mail address: rawa_ramahi@najah.edu/ jeghRowa Al-Ramahi *Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University,
P.O. Box: 7, Nablus, PalestineReceived 2 August 2013; received in revised form 8 May 2014; accepted 14 May 2014
Available online 21 June 2014KEYWORDS
Adherence;
Hypertension;
Forgetfulness;
PalestineAbstract Objective: To assess adherence of Palestinian hypertensive patients to
therapy and to investigate the effect of a range of demographic and psychosocial
variables on medication adherence.
Methods: A questionnaire-based, cross-sectional descriptive study was under-
taken at a group of outpatient clinics of the Ministry of Health, in addition to a group
of private clinics and pharmacies in the West Bank. Social and demographic variables
and self-reported drug adherence (Morisky scale) were determined for each patient.
Results: Low adherence with medications was present in 244 (54.2%) of the
patients. The multivariate logistic regression showed that younger age (<45 years),
living in a village compared with a city, evaluating health status as very good, good
or poor compared with excellent, forgetfulness, fear of getting used to medication,
adverse effect, and dissatisfaction with treatment had a statistically significant
association with lower levels of medication adherence (P < 0.05).
Conclusions: Poor adherence to medications was very common. The findings of
this study may be used to identify the subset of population at risk of poor adherence
who should be targeted for interventions to achieve better blood pressure control
and hence prevent complications. This study should encourage the health policy
makers in Palestine to implement strategies to reduce non-compliance, and thus
contribute toward reducing national health care expenditures. Better patient
education and communication with healthcare professionals could improve some
factors that decrease adherence such as forgetfulness and dissatisfaction with
treatment.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
126 R. Al-Ramahi1. Introduction
The World Health Organization defines adherence
as ‘‘the extent to which a persons behavior-taking
medication, following a diet, and/or executing
lifestyle changes corresponds with agreed recom-
mendations from a health-care provider’’ [1].
Generally, adherence to a medical regimen is most
likely to be a problem in chronic diseases such as
diabetes, hypertension, coronary artery disease,
osteoporosis, and asthma, and is responsible for
suboptimal clinical outcomes, decreased quality
of life, and increased expense to the health-care
system [1–3]. Poor adherence to treatment of
chronic diseases is a worldwide problem of striking
magnitude. According to the World Health Organi-
zation adherence to long-term therapy for chronic
illnesses in developed countries averages 50%. In
developing countries, the rates are even lower [1].
Hypertension is a significant public health prob-
lem in many countries. It remains an important
public health challenge and one of the most
important risk factors for coronary heart disease,
stroke, heart failure and end stage renal disease
[4,5]. Lowering blood pressure by antihypertensive
drugs reduces the risks of cardiovascular events,
stroke, and total mortality [6,7]. Lack of compli-
ance with blood pressure-lowering medication is a
major reason for poor control of hypertension.
Patients with high blood pressure may fail to take
their medication because of the chronic nature of
the disease and the absence of overt symptoms
[8]. In Palestine, hypertension is among the leading
causes of death; it is the eighth cause of death and
is a risk factor for cardiovascular and cerebrovas-
cular diseases which represent the first and second
causes of death [9].
Factors that affect medication adherence are
complex; low adherence was reported among
younger individuals, men, and black persons. Other
factors that were reported to negatively impact
adherence to prescribed therapies include beliefs
about illness and treatment, forgetfulness, side
effects of medications, complexity of treatment
regimens, lack of knowledge regarding hyperten-
sion and its treatment, financial difficulties, psy-
chological factors, social support, quality of the
relationship between patient and physician and
poor quality of life [5,10–16].
Studies related to medication adherence are
very limited in Palestine. Compared with other
variables being considered in therapeutics, adher-
ence to medications has long been given minor
attention although it affects every aspect of med-
ical care. This study appears to be the first toinvestigate the rate of medication adherence and
its associated factors in hypertensive patients from
the West Bank. The objectives of this study are to
measure the rate of medication adherence, to
investigate the factors associated with this adher-
ence and the reasons for poor adherence. This
study could be helpful to health policy makers in
Palestine to implement health education strategies
to reduce poor adherence and thus to reduce com-
plications of the disease and national health costs.
2. Methods
2.1. Patient selection
The study was a questionnaire-based cross-sec-
tional descriptive study. It was conducted between
September and December 2011. It included a sim-
ple random sample from patients visiting outpa-
tient clinics of governmental primary healthcare
centers in addition to a group of private clinics
and pharmacies in the West Bank. Approval to per-
form the study was obtained from the Palestinian
Ministry of Health (MOH) and the Institutional
Review Board (IRB) committee at An-Najah
National University. The study complied with the
Declaration of Helsinki and did not endanger
the well-being of the patients. Patients who met
the following criteria were invited to participate
in this study: (1) PatientsP 18 years; (2) Those
who had been diagnosed with hypertension; and
(3) Those who were on prescribed antihypertensive
medications for at least one month. Patients who
agreed to participate were explained the nature
and the objectives of the study, and informed
consent was formally obtained.
Since there was no available literature showing
the prevalence of adherence among the Palestinian
community in general, a 50% expected prevalence
was used; minimum sample size was calculated to
be 384, so 500 patients were asked to participate
in the study.2.2. Data collection
The data collection tool was a questionnaire,
designed-based on an extensive literature review
of similar studies [2,5,17]. The questionnaire
included information regarding patient demo-
graphics and clinical characteristics such as: sex,
age, education, insurance, income, medical his-
tory, and co-morbidities. Patients were asked
about their prescribed medication regimen, includ-
ing the number of their antihypertensive drugs and
other medications – if present – frequency per
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not taking their medications. Adherence was
assessed through the 8-item self-report Morisky
Medication Adherence Scale (MMAS) [5]. Each item
measures a specific medication-taking behavior.
Approval was obtained from professor Morisky to
use his scale. This scale is a questionnaire with a
high reliability and validity, which has been partic-
ularly useful in chronic conditions such as hyper-
tension [5,12]. Highly adherent patients were
identified with the score of 8 on the scale, medium
adherers with a score of 6 to <8, and low adherers
with a score of <6. For studying factors affecting
adherence, patients were divided into two groups:
poor adherent (score < 6) versus adherent (score
6–8), because in the Morisky et al. study, correct
classification with blood pressure control was
based on a dichotomous low versus high/medium
level of adherence, which had a rate of 80.3%.
When they used a cut-off point of <6, the sensitiv-
ity of the measure to identify patients with poor
blood pressure control was estimated to be 93% [5].
Forward translation of the original scale was
undertaken by translation from English to the Arabic
language to produce a version that was semantically
and conceptually as close as possible to the original
questionnaire. Then reverse translation of this ver-
sion from Arabic to English was carried out by
another translator. After discussion between the
translators and the researchers, inconsistencies
were resolved and a final version, ready for testing,Table 1 Responses to Morisky scale questions.
Number Question
1 Do you sometimes forget to take your
high blood pressure pills?
2 Over the past 2 weeks, were there any days
when you did not take your high blood press
3 Have you ever cut back or stopped taking yo
medication without telling your doctor
because you felt worse when you took it?
4 When you travel or leave home, do you
sometimes forget to bring along your medica
5 Did you take your high blood pressure medic
6 When you feel like your blood pressure is un
control, do you sometimes stop taking your m
7 Do you ever feel hassled about sticking to yo
pressure treatment plan?
8 How often do you have difficulty rememberi
all your blood pressure medication?
Never 172 (38.2%)
Once in a while 148 (32.9%)
Sometimes 81 (18.0%)
Usually 28 (6.2%)
All the time 21(4.7%)was generated. The translated questionnaire was
distributed to 20 patients who completed the ques-
tionnaire and commented on the questions. These
individuals were not included in the study.
2.3. Data analysis
Statistical analyses were performed using SPSS ver-
sion 16 (SPSS, Chicago, IL, USA). Means ± standard
deviation was computed for continuous data.
Frequencies and percentages were calculated for
categorical variables. In univariate analyses, cate-
gorical variables were compared using Chi-square
test. Multivariate logistic regression analysis was
conducted to evaluate the odds ratios of factors
that showed a statistically significant association
with medication adherence in the univariate analy-
sis. A P-value < 0.05 was considered statistically
significant.
3. Results
3.1. Participants characteristics
From 500 people approached, 450 (90.0%) agreed
to participate in the study. Females accounted
for 253 (56.2%) of the total sample. The average
age was 59.1 (±12.2) years (from 27 to 90 years).
Around one half of the participants (241, 53.6%)
had another chronic disease and more than two-
thirds of them (317 70.4%) had a governmentalYes No
Frequency (%) Frequency (%)
262 (58.2) 188 (41.8)
ure medicine?
162 (36.0) 288 (64.0)
ur 124 (27.6) 326 (72.4)
tions?
181 (40.2) 269 (59.8)
ine yesterday? 378 (84.0) 72 (16.0)
der
edicine?
128 (28.4) 322 (71.6)
ur blood 216 (48.0) 234 (52.0)
ng to take
Table 2 Univariate analysis of the association of potential demographic and clinical variables with self-reported
adherence.
Characteristic Total sample MMAS category (score range) P value
N = 450 Low (<6) Medium/High
(6–8)
N = 244 N = 206
N (%) N (%)
Age 0.006
18–44 41 32 (78.0) 9 (22.0)
45–64 259 134 (51.7) 125 (48.3)
P65 150 78 (52.0) 72 (48.0)
Gender 0.972
Male 197 107 (54.3) 90(45.7)
Female 253 137 (54.2) 116 (45.8)
Education 0.590
College/ university or higher 129 66 (51.2) 63 (48.8)
High school 118 68 (57.6) 50 (42.4)
Primary/ middle school 112 64 (57.1) 48 (42.9)
Illiterate 91 46 (50.5) 45(49.5)
Area of residence 0.001
City 233 106 (45.5) 127 (54.5)
Village 175 111 (63.4) 64 (36.6)
Camp 42 27 (64.3) 15 (35.7)
Household monthly income 0.035
<400 JD 247 145 (58.7) 102 (41.3)
P400 JD 203 99 (48.8) 104 (51.2)
Marital status 0.088
Single 26 16 (61.5) 10 (38.5)
Married 341 178 (52.2) 163 (47.8)
Divorced 17 14 (82.4) 3 (17.6)
Widowed 66 36 (54.5) 30 (45.5)
Health insurance 0.505
Governmental 317 169 (53.3) 148 (46.7)
Private 42 21 (50.0) 21 (50.0)
No insurance 91 54 (59.3) 37 (40.7)
Current health status 0.012
Excellent 24 7 (29.2) 17 (70.8)
Very good 123 75 (61.0) 48 (39.0)
Good 178 102 (57.3) 76 (42.7)
Poor 125 60 (48.0) 65 (52.0)
Another chronic disease 0.009
Yes 241 117 (48.5) 124 (51.5)
No 209 127 (60.8) 82 (39.2)
Number of tablets per day 0.001
1 140 59 (42.1) 81 (57.9)
2 150 85 (56.7) 65 (43.3)
P3 160 100 (62.5) 60 (37.5)
Number of medications per day 0.496
1 221 114 (51.6) 107 (48.4)
2 163 94 (57.7) 69 (42.3)
P3 66 36 (54.5) 30 (45.5)
Frequency of dosing <0.0001
1 192 80 (41.7) 112 (58.3)
>1 258 164 (63.6) 94 (36.4)
128 R. Al-Ramahihealth insurance plan. The mean number of antihy-
pertensive medications was 2.35 (±1.49). Based on
the MMAS, only 76 (16.9%) participants had highadherence, 130 (28.9%) had medium adherence
and 244 (54.2%) had poor adherence. Table 1 shows
the responses to the Morisky scale questions.
Table 4 Odds ratios of determinants of poor medication
adherence.
Odd
ratio (OR)
95% confidence
interval (CI)
Age
18–44 1
45–64 0.40 0.157–0.99
P65 0.32 0.12–0.87
Area of residence
City 1
Village 1.79 1.10–2.92
Current health status
Excellent 1
Very good 5.58 1.83–17.04
Good 5.40 1.78–16.32
Poor 4.55 1.44–14.41
Forgetfulness 5.12 3.12–8.41
Dissatisfaction with
treatment
2.93 1.22–7.02
Side effects 4.58 1.87–11.25
Fear of getting used
to medication
8.00 2.44–26.19
Adherence to medications and associated factors 129In univariate analysis, factors that were associ-
ated with poor medication adherence were youn-
ger age, living in a village or a camp, having
lower income, receiving a higher number of antihy-
pertensive tablets daily or a higher dosing fre-
quency, evaluating health status as very good,
good or poor, and having no other chronic disease,
(p < 0.05). The main socio-demographic and clini-
cal baseline characteristics of the responders and
their association with poor adherence are shown
in Table 2.
Patients reasons for low-adherence to medica-
tions were recorded as forgetfulness 275 (61.1%),
cost 72 (16.0%), lack of access to medication 66
(14.7%), traveling 53 (11.8%), dissatisfaction with
treatment 45 (10.0%), adverse effect 45 (10.0%),
fear of getting used to medication 33 (7.3%), and
other reasons such as the unavailability of these
medications at the Ministry of Health healthcare
centers 40 (8.9%). Among these reasons, forgetful-
ness, fear of getting used to medication, adverse
effect, and dissatisfaction with treatment had a
statistically significant association with poor adher-
ence (Table 3).
The multivariate logistic regression showed that
younger age (<45 years), living in a village com-
pared to a city, evaluating health status as very
good, good or poor compared with excellent, for-
getfulness, fear of getting used to medication,
adverse effect, and dissatisfaction with treatment
had a statistically significant association with lower
levels of medication adherence (P < 0.05) as shown
in Table 4.
The Chi-square test showed a significant rela-
tionship between MMAS categories and reported
control of blood pressure. Among the patients,
113 (25.1%) reported that their blood pressure
measurements were within the goal all the time,
284 (63.1) said they were within the goal some-
times, and 53 (11.8%) reported that their measure-
ments were above the goal all the time (Fig. 1).Table 3 Patients reasons for non-adherence to medications.
Factor Total no.
Forgetfulness 275
Cost of medication 72
Lack of access to medication 66
Traveling 53
Dissatisfaction with treatment 45
Side effects 45
Others 40
Fear of getting used to medication 334. Discussion
Medication adherence is a key component of treat-
ment for patients with hypertension. This study
found a very high percentage of low adherence
(54.2% of patients). This means that for many
hypertensive patients, medication adherence
needs to be improved. This result is close to what
has been reported from Taiwan (47.5%) [18], Saudi
Arabia (47.0%) [19], and Pakistan (64.7%) [11]. It is
higher than studies from the United States (9.0%)
[12], Egypt (25.9%) [20] and Ethiopia (35.4%) [21].
However, the lack of standard measurements pre-
vents comparisons being made between studies
and across populations.
In this study, younger age (<45 years), living in a
village compared with a city, evaluating healthMMAS category (score range) P value
Low (<6) Medium/High (6–8)
No. (%) No. (%)
179 (65.1) 96 (34.9) <0.0001
40 (55.6) 32(44.4) 0.804
41 (62.1) 25 (37.9) 0.163
34 (64.2) 19 (35.8) 0.122
36 (80.0) 9 (20.0) <0.0001
35 (77.8) 10(22.2) 0.001
19 (47.5) 21 (52.5) 0.371
29 (87.9) 4 (12.1) <0.0001
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130 R. Al-Ramahistatus as very good, good or poor compared with
excellent, forgetfulness, fear of getting used to
medication, adverse effect, and dissatisfaction
with treatment had a statistically significant asso-
ciation with lower levels of medication adherence
(P < 0.05) in multivariate logistic regression. Effect
of age is consistent with some other studies; for
example, in a study from the United Kingdom,
patients over the age of 50 were found to be more
adherent than those in the younger age groups
[22], and in Pakistan, subjects who were less than
40 years old were less adherent than those older
than 70. The highest mean adherence rate was
observed in the age group 70–80 years [17]. It
seems that the people care more when they get
older and/or start to have disease complications.
This should be considered during patient counsel-
ing; complications of hypertension in addition to
risks of poor adherence to medications should be
explained well to patients in the younger age
groups. Living in a village compared with a city
was a reason for poor adherence also; this may
be related to lower levels of education or income
in addition to difficulties in reaching doctors and
health-care facilities. Evaluating health status as
very good, good or poor compared with excellent
was significantly associated with poor adherence.
In some studies, lower medication adherence was
associated with poor health-related quality of life
[11]. Poor health may cause the patient to be
depressed and less satisfied with his medications.
Forgetting to take medication was the main reason
for low-adherence in this study similar to otherstudies [13,17]; efforts of greater emphasis on this
point are recommended. Adverse effects are well-
known reasons for poor adherence to medications
[19,20]. The patients who were fearful of getting
used to medication and who were dissatisfied with
treatment were significantly associated with poor
adherence. Better communication with prescribers
and pharmacists might solve these problems. It can
be noticed that a low level of adherence was not
influenced by sex or by the level of education. This
might reflect an important cultural behavior that
could influence the proposed strategies to improve
adherence. They should cover both males and
females from different educational levels.
Better communication with health-care provid-
ers and better education about the medications
and the nature of the disease can be of a great
value in improving patients adherence to their
medications. Identifying patients at high risk for
poor adherence can help in interventions to
improve adherence. These interventions can be
educational interventions. Education may take
the form of individual instruction or group classes.
Effective interventions can be behavioral
approaches that use techniques such as reminders,
memory aids, and synchronizing therapeutic activ-
ities with routine life events (e.g., taking pills
before you shower or after your prayers) [23].
Effective interventions seek to enhance adherence
by providing emotional support and encourage-
ment. It should be remembered that the applica-
tion of multiple interventions of different types is
more effective than any single intervention [16].
Adherence to medications and associated factors 131It is of utmost importance to discuss the impedi-
ments faced by each patient and to work together
as partners to overcome them. It is only then that
the full benefits of adherence and the effective
control of blood pressure will be achieved [20].
In this study, blood pressure control level was
associated with adherence behavior. Those with
controlled blood pressure were observed to be
adherent. This finding is in line with other studies
[5,15]. It might be attributable to a better out-
come of the treatment; this may offer the patient
good satisfaction and create a strong motivation
toward the treatment. However, a bad outcome
(uncontrolled BP) could make the patient hopeless
and has a low satisfaction level, which may lead
them to stop their treatment [21].
5. Limitations
The limitation of this study is that it used a self-
report questionnaire to assess adherence; this
method has the disadvantages of recall bias and
eliciting only socially acceptable responses, and
hence, it may overestimate the level of adherence.
However, self-reported measures are simple and
economical to use and can provide real-time feed-
back regarding adherence behavior and potential
reasons for poor adherence [5].
6. Conclusions
More than half of the study participants were found
to have low adherence. This means that for many
hypertensive patients, medication adherence
needs to be improved. A number of associations
were identified between patient factors and adher-
ence to antihypertensive drugs. These findings may
be used to identify the subset of population at risk
of poor adherence who should be targeted for
interventions to achieve better blood pressure con-
trol and hence prevent complications.
Better patient education and communication
with health-care professionals could improve some
factors that decrease adherence, such as forgetful-
ness and dissatisfaction with treatment.
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